1 Min Read
* Says it plans to buy 95.02 percent stake in pharmaceuticals firm, for up to T$200 million
Source text in Chinese: goo.gl/tqxTby
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.